The World Health Organization (WHO) classification recognizes MLL-leukemias as a recurrent genetic abnormality under AML, B-cell acute lymphoblastic leukemia (B-ALL), and acute leukemias of an ambiguous lineage [22]. Here, KMT2A is linked to acute lymphoblastic leukemia.